The effect of lipophilicity on antifungal activity of some 2-amino and 2-methylbenzimidazole derivatives

Chemicke Listy

Volumn 102, Issue 15 SPEC. ISS., 2008, Pages

  Podunavac Kuzmanović, Sanja O ^a   Cvetković, Dragoljub D ^a   Barna, Dijana J ^a  

^a UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 54349121090     PISSN: 00092770     EISSN: 12137103     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Goker H., Alp M., Yildiz S.: Molecules 10, 1377 (2000).
2. Nguyen P. T. M., Baldeck J. D., Olsson J., Marquis R. E.: Oral Microbiol. Immunol. 20, 93 (2005).
3. Podunavac-Kuzmanović S. O., Leovac V. M., Perišić- Janjić N. U., Rogan J., Balaž J.: J. Serb. Chem. Soc. 64, 381 (1999).
4. Podunavac-Kuzmanović S. O., Cvetković D.: J. Serb. Chem. Soc. 75, 381 (2007).
5. Ayhan-Kilcigil G., Altanlar N.: Turk. J. Chem. 30, 223 (2006).
6. Boiani M., Gonzalez M.: J. Med. Chem. 5, 409 (2005).
7. Garuti L., Roberti M., Cermelli C.: Bioorg. Medicinal Chem. Letter 9, 2525 (1999).
8. Kazimierczuk Z., Upcroft J. A ., Upcroft P., Gorska A., Starosciak B., Laudy A.: Acta Biochim. Polon. 49, 185 (2002).
9. Akbay A., Oren I., Temiz-Arpaci O., Aki-Sener E., Yalcin I.: Arzneim.-Forcsh./Drug Res. 53, 266 (2003).
10. Bevan D.: QSAR and Drug Design. Network Science, http://www.netsci.org/Science/Compchem/feature12.html.
11. QSAR, The Australian Computational Chemistry via the InternetProject,www.chem.swin.edu.au/modukes/mod4/index.html.
12. Hansch C.: J. Med. Chem. 19, 1 (1976).
13. Vasanthanathan P., Lakshmi M., Babu M. A ., Gupta A. K., Kaskhedikar S. G.: Chem. Pharm. Bull. 54, 583 (2006).
14. Melagraki G., Afantitis A., Sarimveis H., Igglessi-Markopoulou O., Supuran C. T.: Bioorg. Med. Chem. 14, 1108 (2006).
15. Podunavac-Kuzmanović S. O ., Markov S. L., Barna D. J.: J. Theor. Comp. Chem. 6, 687 (2007).
16. Podunavac-Kuzmanović, S. O ., Barna, D. J., Cvetković D. M .: Acta Periodica Technol. 38, 139 (2007).
17. Leo A., Hansch C., Elkins D.: Chem. Rev. 71, 525 (1971).
18. Nasal A., Siluk D., Kaliszan R.: Curr. Med. Chem. 10, 381 (2003).
19. Tiperciuc B, Sarbu C.: J. Liq. Chrom. Rel. Technol. 29, 2257 (2006).
20. Perišić-Janjić N. U., Podunavac-Kuzmanović S. O .: J. Planar Chromatogr. 21, 135 (2008).
21. Perišić-Janjić N. U., Podunavac-Kuzmanović S. O ., Balaž, J. S., Vlaović Dj.: J. Planar Chromatogr. 13, 123 (2000).
22. Slawik T., Paw B.: J. Liq. Chromatogr. 27, 1043 (2004).
23. Vaović Crossed D sign., Čanadanović-Brunet J., Balaž J., Juranić I., Crossed D signoković D., Mackenzie K.: Biosci. Biotech. Biochem. 56, 199 (1992).
24. National Committee for Clinical Laboratory Standards, NCCLS Approval Standard Document M2-A7. Vilanova, Pa, U.S.A. 2000.
25. National Committee for Clinical Laboratory Standards, NCCLS Approval Standard Document M7-A5. Vilanova, Pa, U.S.A. 2000.
26. CS. Chem. Office, Version 7.0, Cambridge Soft Corporation, 100 Cambridge Park Drive, Cambridge, MA 02140-2317, U.S.A. 2001.
27. www.ncss.com.
28. Lien E. J.: Side Effects and Drug Design. Marcel Dekker, New York 1987.
29. Jalali-Heravi M., Kyani A.: J. Chem. Inf. Comput. Sci. 44, 1328 (2004).